DiaSorin Receive Clearance for LIAISON® CMV and EBV Assays
go back to news archivesDiaSorin Inc. have recently received FDA clearance for their LIAISON® Cytomegalovirus assays, including CMV IgG/CMV IgM and Epstein-Barr Virus assays, including VCA IgM, VCA IgG and EBNA IgG
The LIAISON® analyser combines a flexible operating mode with a broad assay menu and leads to high efficiency due to its long walk-away time. The possibility to run up to 15 different assays at a time provides for rational everyday testing even for low numbers of samples. Moreover, a throughput of up to 180 determination per hour allows LIAISON® to cope easily with a very high volume of samples. It is easy to use due to its touch-screen monitor, clear software structure and the Reagent Integral which contains all assay-specific reagents.
"Flash" chemiluminescence detection system
Paramagnetic microparticle solid phase
Sample and reagent continuous loading
Random access or batch mode
2-point calibration
STAT
Autodilution
Maximum through put: ~180 results/h
Source : DiaSorin Inc. [USA] View archived contact details
Is a subsidiary/distributor for
DiaSorin S.p.A., Italy View Company Information
Posted on July 25, 2005
LATEST MICROBIOLOGY NEWS
-
New Self-collection Devices from MWE
01 Jul 2025
MICROBIOLOGY EVENTS
-
AI for Food Safety Professionals
8 Jul 2025 -
Getting Equipped for the Future with the New MAS-100 Sirius® Microbial Air Sampler
10 Jul 2025 -
FEMS Micro
14 Jul 2025 -
Unmasking Endotoxins: A Sample Preparation Strategy to Overcome LER
15 Jul 2025 -
IAFP 2025
27 Jul 2025 -
ADLM 2025
27 Jul 2025 -
Food Safety Culture Workshop
9 Sep 2025 -
CPD accredited course: Level 3 HACCP & Food Safety
15 Sep 2025 -
Culture Eats HACCP for Breakfast (free)
On-demand Webinar -
A3P International Congress 2025
7 Oct 2025